XML 37 R25.htm IDEA: XBRL DOCUMENT
v3.19.1

Fair Value Measurements (Tables) | 9 Months Ended
--- | ---
Feb. 28, 2019
Fair Value Disclosures [Abstract] |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | The following tables present information about the Company’s financial assets measured at fair value on a recurring basis as of February 28, 2019 and May 31, 2018, and indicate the level in the fair value hierarchy in which the Company classifies the fair value measurement.
|  | As of February 28, 2019
(In millions) |  | Assets at Fair Value |  | Cash and Equivalents |  | Short-term Investments
Cash |  | $ | 540 |  |  | $ | 540 |  |  | $ | — |
Level 1: |  |  |  |  |  |
U.S. Treasury securities |  | 417 |  |  | 100 |  |  | 317 |
Level 2: |  |  |  |  |  |
Commercial paper and bonds |  | 31 |  |  | 1 |  |  | 30 |
Money market funds |  | 1,379 |  |  | 1,379 |  |  | — |
Time deposits |  | 1,678 |  |  | 1,675 |  |  | 3 |
U.S. Agency securities |  | 1 |  |  | — |  |  | 1 |
Total Level 2: |  | 3,089 |  |  | 3,055 |  |  | 34 |
TOTAL |  | $ | 4,046 |  |  | $ | 3,695 |  |  | $ | 351 |
|  | As of May 31, 2018
(In millions) |  | Assets at Fair Value |  | Cash and Equivalents |  | Short-term Investments
Cash |  | $ | 415 |  |  | $ | 415 |  |  | $ | — |
Level 1: |  |  |  |  |  |
U.S. Treasury securities |  | 1,178 |  |  | 500 |  |  | 678 |
Level 2: |  |  |  |  |  |
Commercial paper and bonds |  | 451 |  |  | 153 |  |  | 298 |
Money market funds |  | 2,174 |  |  | 2,174 |  |  | — |
Time deposits |  | 925 |  |  | 907 |  |  | 18 |
U.S. Agency securities |  | 102 |  |  | 100 |  |  | 2 |
Total Level 2: |  | 3,652 |  |  | 3,334 |  |  | 318 |
TOTAL |  | $ | 5,245 |  |  | $ | 4,249 |  |  | $ | 996 |
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | The following tables present information about the Company’s derivative assets and liabilities measured at fair value on a recurring basis as of February 28, 2019 and May 31, 2018, and indicate the level in the fair value hierarchy in which the Company classifies the fair value measurement.
|  | As of February 28, 2019
|  | Derivative Assets |  | Derivative Liabilities
(In millions) |  | Assets at Fair Value |  | Other Current Assets |  | Other Long-term Assets |  | Liabilities at Fair Value |  | Accrued Liabilities |  | Other Long-term Liabilities
Level 2: |  |  |  |  |  |  |  |  |  |  |  |
Foreign exchange forwards and options(1) |  | $ | 481 |  |  | $ | 414 |  |  | $ | 67 |  |  | $ | 83 |  |  | $ | 83 |  |  | $ | — |
Embedded derivatives |  | 7 |  |  | 1 |  |  | 6 |  |  | 6 |  |  | 4 |  |  | 2 |
TOTAL |  | $ | 488 |  |  | $ | 415 |  |  | $ | 73 |  |  | $ | 89 |  |  | $ | 87 |  |  | $ | 2 |
(1) | If the foreign exchange derivative instruments had been netted on the Unaudited Condensed Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $82 million as of February 28, 2019. As of that date, the Company had received $137 million of cash collateral from various counterparties related to foreign exchange derivative instruments. No amount of collateral was posted on the Company’s derivative liability balance as of February 28, 2019.
|  | As of May 31, 2018
|  | Derivative Assets |  | Derivative Liabilities
(In millions) |  | Assets at Fair Value |  | Other Current Assets |  | Other Long-term Assets |  | Liabilities at Fair Value |  | Accrued Liabilities |  | Other Long-term Liabilities
Level 2: |  |  |  |  |  |  |  |  |  |  |  |
Foreign exchange forwards and options(1) |  | $ | 389 |  |  | $ | 237 |  |  | $ | 152 |  |  | $ | 182 |  |  | $ | 182 |  |  | $ | — |
Embedded derivatives |  | 11 |  |  | 3 |  |  | 8 |  |  | 8 |  |  | 2 |  |  | 6 |
TOTAL |  | $ | 400 |  |  | $ | 240 |  |  | $ | 160 |  |  | $ | 190 |  |  | $ | 184 |  |  | $ | 6 |
(1) | If the foreign exchange derivative instruments had been netted on the Condensed Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $182 million as of May 31, 2018. As of that date, the Company had received $23 million of cash collateral from various counterparties related to these foreign exchange derivative instruments. No amount of collateral was posted on the Company’s derivative liability balance as of May 31, 2018.
The following table presents the fair values of derivative instruments included within the Unaudited Condensed Consolidated Balance Sheets as of February 28, 2019 and May 31, 2018. Refer to Note 4 — Fair Value Measurements for a description of how the financial instruments in the table below are valued.
|  | Derivative Assets |  | Derivative Liabilities
(In millions) |  | Balance Sheet Location |  | February 28, 2019 |  | May 31, 2018 |  | Balance Sheet Location |  | February 28, 2019 |  | May 31, 2018
Derivatives formally designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |  |
Foreign exchange forwards and options |  | Prepaid expenses and other current assets |  | $ | 343 |  |  | $ | 118 |  |  | Accrued liabilities |  | $ | 58 |  |  | $ | 156 |
Foreign exchange forwards and options |  | Deferred income taxes and other assets |  | 67 |  |  | 152 |  |  | Deferred income taxes and other liabilities |  | — |  |  | — |
Total derivatives formally designated as hedging instruments |  |  |  | 410 |  |  | 270 |  |  |  |  | 58 |  |  | 156 |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |  |
Foreign exchange forwards and options |  | Prepaid expenses and other current assets |  | 71 |  |  | 119 |  |  | Accrued liabilities |  | 25 |  |  | 26 |
Embedded derivatives |  | Prepaid expenses and other current assets |  | 1 |  |  | 3 |  |  | Accrued liabilities |  | 4 |  |  | 2 |
Foreign exchange forwards and options |  | Deferred income taxes and other assets |  | — |  |  | — |  |  | Deferred income taxes and other liabilities |  | — |  |  | — |
Embedded derivatives |  | Deferred income taxes and other assets |  | 6 |  |  | 8 |  |  | Deferred income taxes and other liabilities |  | 2 |  |  | 6 |
Total derivatives not designated as hedging instruments |  |  |  | 78 |  |  | 130 |  |  |  |  | 31 |  |  | 34 |
TOTAL DERIVATIVES |  |  |  | $ | 488 |  |  | $ | 400 |  |  |  |  | $ | 89 |  |  | $ | 190 |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19190-110258 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration